LDS/Medical Tests/ALICE (Analysis of Infectious Chronic Endometritis) and EMMA (Endometrial Microbiome Metagenomic Analysis)

ALICE (Analysis of Infectious Chronic Endometritis) and EMMA (Endometrial Microbiome Metagenomic Analysis)

ALICE is a molecular diagnostic test developed by Igenomix that detects and quantifies the pathogenic bacteria most commonly responsible for chronic endometritis, a persistent, often asymptomatic inflammation of the endometrium found in up to 30% of infertile women and up to 60-66% of women with recurrent implantation failure or recurrent pregnancy loss. The test is performed on a small piece of endometrial biopsy tissue and can share the same biopsy used for the ERA test, avoiding an additional sampling procedure. Chronic endometritis is not reliably detected by ultrasound or standard gynecologic exam, and traditional diagnostic methods (histology, hysteroscopy, microbial culture) produce inconclusive or misleading results in a substantial proportion of cases; ALICE was developed to provide a more consistent, culture-independent alternative.

ALICE identifies patients whose endometrial microbiological environment may be unfavorable to implantation, allowing targeted antibiotic and probiotic treatment before embryo transfer. It is indicated for any patient wishing to conceive, and particularly for patients with a history of recurrent implantation failure or recurrent pregnancy loss, given the strong association between chronic endometritis and these outcomes.

EMMA is a test that analyses the endometrial microbiome to help identify abnormalities associated with a poor reproductive prognosis. EMMA assesses the endometrial microbiome, providing information about the most common and relevant bacteria, including those linked to higher pregnancy rates. EMMA is a Real-time PCR analysis for 31 bacterial DNA targets from endometrial biopsy, reported with quantified levels of bacterial presence and targeted treatment. EMMA also includes ALICE, which detects pathogenic bacteria that can cause chronic endometritis.

  • Aids in the diagnosis of chronic endometritis associated with infertility
  • Indicated for any patient trying to conceive who has had difficulty becoming pregnant
  • Treatment guided by a positive result is associated with improved reproductive outcomes in infertile patients undergoing IVF

The report indicates the presence and relative abundance of specific bacteria associated with chronic endometritis.

Positive Result: Pathogenic bacteria associated with chronic endometritis were detected (e.g., Enterococcus spp., Enterobacteriaceae [including E. coli, Klebsiella pneumoniae], Streptococcus spp., Staphylococcus spp., Mycoplasma spp., Ureaplasma spp., or the STI-associated organisms Chlamydia trachomatis/Neisseria gonorrhoeae). Targeted antibiotic therapy (with probiotic follow-up) is recommended, and embryo transfer is typically postponed until treatment is confirmed successful by a repeat test.

Negative Result: No significant abundance of the targeted chronic endometritis-associated pathogens was detected. This does not rule out endometrial pathogens outside the ALICE panel.

Negative (No significant abundance of the targeted chronic endometritis-associated pathogens was detected)

Bacterial DNA is extracted from endometrial tissue and analyzed by amplification and barcoded next-generation sequencing (NGS) of the bacterial 16S ribosomal RNA gene, which contains species-specific variable regions allowing taxonomic assignment and relative quantification of bacteria while distinguishing bacterial from human DNA in the same sample. The assay targets organisms most commonly implicated in chronic endometritis, including Enterococcus spp., Enterobacteriaceae (E. coli, Klebsiella pneumoniae), Streptococcus spp., Staphylococcus spp., Mycoplasma spp., and Ureaplasma spp., as well as the sexually transmitted pathogens Chlamydia trachomatis and Neisseria gonorrhoeae.

A small endometrial biopsy is collected from the uterine cavity under sterile conditions using a Pipelle de Cornier (or equivalent) catheter, in either a natural or hormone replacement therapy (HRT) cycle. The tissue is placed directly into the Igenomix collection cryotube (no need to expel it from the pipelle tip), refrigerated at 4-8°C for a minimum of 4 hours, and can then be kept refrigerated for up to 3 weeks or frozen at -20°C for up to 1 year (freezing is not recommended for extended storage, as the microbiota can change over time); samples are generally stable at room temperature for 5-7 days if shipping is delayed.

ALICE is frequently ordered together with ERA and EMMA (as the EndomeTRIO panel) using a single endometrial biopsy. A Positive result should prompt antibiotic (and subsequent probiotic) treatment with a repeat ALICE test to confirm clearance before embryo transfer; antibiogram-guided therapy is used if a second positive result occurs. Microbiology counseling is available through the laboratory for patients or providers.

1-2 weeks. 

Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login